SOX2 and neoplasm: Overexpression of SOX2 and related aberrant interacts with various signaling pathways such as unchecked proliferation, apoptosis resistance, altered autophagy, enhanced EMT, and maintenance of CSCs, promoting tumor development, metastasis, and treatment resistance [266].